Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202510463370770Phase 0Recruiting
Phase 0, open-label trial in cutaneous aging, periorbital rhytides and None, sponsored by Cairo University. Primary endpoint: Primary efficacy of synthetic exosomes in periorbital rejuvenation. Started Oct 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202510463370770.